Searchable abstracts of presentations at key conferences in endocrinology

ea0066oc4.1 | Oral Communications 4 | BSPED2019

Mortality after childhood growth hormone treatment in the UK – the SAGhE study

Cooke Rosie , Swerdlow Anthony , Clayton Peter , Tollerfield Sally , Butler Gary

Background: Recombinant human growth hormone (r-hGH) has been used for more than 30 years and indications for r-hGH have multiplied worldwide. There has been concern that it might raise mortality, but published data are limited.Methods: The cohort comprised of 3902 UK patients over 18 years of age in 2009, treated with childhood r-hGH at all the major UK growth centres. The total European cohort was 24 232 from eight countries (including the UK), with > ...